Back
Adaptimmune Therapeutics PLC Stock Predictions
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
37
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.21
Seasonality Move:
-0.77%
7 Day Trial
ALL ACCESS PASS
$
7
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.Adaptimmune Therapeutics PLC Stock Forecast
-
Is Adaptimmune Therapeutics PLC Stock Undervalued?
The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.19. The Score for ADAP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal. - ADAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Adaptimmune Therapeutics PLC Stock Go Up Next Year?
Data Unavailable
Adaptimmune Therapeutics PLC Stock Rating
Data Unavailable
Adaptimmune Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
adaptimmune.com
52-Week Data
52-Week High:
2.05
52-Week Low:
0.42
Prediction Charts
Market Cap:
292.73M
Price in USD:
1.19
Volume:
648.5K
Beta:
2.21
Technical Analysis
SMA50:
1.37
SMA100:
1.09
SMA200:
0.90
52-Wk Change:
-16.48%
Stock Predictions
-
Is Adaptimmune Therapeutics PLC stock public?
Yes, Adaptimmune Therapeutics PLC is a publicly traded company. -
What is the Adaptimmune Therapeutics PLC stock quote today?
The Adaptimmune Therapeutics PLC stock price is 1.19 USD today. -
How to buy Adaptimmune Therapeutics PLC stock online?
You can buy Adaptimmune Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-11 | 1.28 | 1.29 | 1.34 | 1.26 |
| Apr-12 | 1.20 | 1.16 | 1.28 | 1.13 |
| Apr-15 | 1.20 | 1.06 | 1.21 | 1.06 |
| Apr-16 | 1.05 | 1.03 | 1.06 | 0.98 |
| Apr-17 | 1.02 | 0.99 | 1.05 | 0.93 |
| Apr-18 | 0.97 | 0.90 | 0.99 | 0.87 |
| Apr-19 | 0.92 | 0.98 | 1.10 | 0.92 |
| Apr-22 | 0.99 | 1.01 | 1.08 | 0.94 |
| Apr-23 | 1.04 | 1.12 | 1.16 | 1.00 |
| Apr-24 | 1.14 | 1.08 | 1.15 | 1.07 |
| Apr-25 | 1.05 | 1.06 | 1.10 | 1.04 |
| Apr-26 | 1.06 | 1.08 | 1.10 | 1.03 |
| Apr-29 | 1.09 | 1.15 | 1.20 | 1.07 |
| Apr-30 | 1.23 | 1.19 | 1.23 | 1.15 |
Adaptimmune Therapeutics PLC Earnings
Data Unavailable
Adaptimmune Therapeutics PLC Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.08 per share.
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.